Neurochem, Inc. and SELECT Therapeutics, Inc. have announced the initiation of a collaboration program to advance a novel vaccine intended to prevent the development and the progression of Alzheimer’s Disease. The vaccine will target the prevention of an accumulation of beta- amyloid, a protein that constitutes a major part of plaques in the brain of Read more about Neurochem And SELECT Therapeutics Collaborate On Alzheimer’s Vaccine[…]